Independent Cleveland Clinic Cardiac Review Supports Potential Best-in-Class Safety Profile as MIRACLE Phase 2b/3 Trial Advances HOUSTON, May 29, 2026 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced new data presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting further reinforcing the differentiated cardiac safety profile of its lead drug candidate, Annamycin (also known as “L-Annamycin” or “naxtarubicin”). The poster presentation, titled “Cardiac safety of L-annamycin at high cumulative anthracycline exposure: Pooled analysis,” highlighted findings from a pooled analysis across five completed clinical trials evaluating Annamycin in patients with acute myeloid leukemia (AML) and soft tissue sarcoma. The analysis demonstrated no detectable cardiotoxicity...

Acquisition Expected to Generate Approximately USD 4 Million in Annual Revenue Opportunities and Strengthen Sagtec’s Position as a Leading F&B Technology Solutions Provider KUALA LUMPUR, Malaysia, May 29, 2026 (GLOBE NEWSWIRE) — Sagtec Global Limited (“Sagtec” or the “Company”) (NASDAQ: SAGT), a leading provider of technology solutions for the food and beverage (“F&B”) industry, today announced that it has entered into a definitive investment agreement to acquire a 40% equity interest in Malaya Heritage Holding Limited (“Malaya Heritage”), a Malaysian F&B group with established restaurant operations and expansion plans. The transaction forms part of Sagtec’s long-term strategy to expand its integrated F&B technology ecosystem by partnering with and...

LONG BEACH, Calif. and TORONTO, May 29, 2026 (GLOBE NEWSWIRE) — Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced the completion of its previously announced redemption of all remaining warrants (the “Warrants”) outstanding under the warrant agency agreement, dated May 13, 2019, between the Company and Odyssey Trust Company, as amended (the “Warrant Agency Agreement”). The Warrants were redeemed on May 28, 2026 (the “Redemption Date”) in accordance with Section 3.4 (1) of the Warrant Agency Agreement at a redemption price of .011826 Shares per Warrant (the “Redemption Shares”) pursuant to a redemption notice dated April 28, 2026. Immediately prior to the redemption, there were 30,644,500 Warrants outstanding....

ROUYN-NORANDA, Québec, May 29, 2026 (GLOBE NEWSWIRE) — Chibougamau Independent Mines Inc. (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart, Berlin and Lang & Schwarz Stock Exchanges in Germany, CMAUF-OTC in the US), herein called Chibougamau, is pleased to report that Tomagold Corporation (LOT-TSXV, TOGOF-OTCPK) has provided an update as regards recent drilling on the Berrigan Mine claims in the Chibougamau area of Quebec. The Berrigan Mine claims and a large number of others are under option from Chibougamau Independent Mines Inc. as updated in a CBG press release dated 2025-09-30. Previous Phase 1 drilling intersected the historical Berrigan Mine mineralization but also in two drill hole TOM-25-015 and Tom-25-014 intersected 5.08 ZnEq (1.19 g/t AuEq over 98.5 m including 23.20% ZnEq over 4.90 m from the new lower zone and...

Over 30 scientific presentations leverage clonoSEQ MRD testing to assess novel therapies and support MRD-guided patient care across blood cancers SEATTLE, May 29, 2026 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced that its next-generation sequencing (NGS)-based clonoSEQ® test for measurable residual disease (MRD) assessment will be included in 33 presentations, including one plenary session and 14 oral presentations, across the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29-June 3 in Chicago, and the European Hematology Association (EHA) Congress, taking place June 11-14 in Stockholm. Data at ASCO...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Vancouver, British Columbia, May 29, 2026 (GLOBE NEWSWIRE) — Deep Sea Minerals Corp. (CSE: SEAS) (OTCQB: DSEAF) (FSE: X450) (“Deep Sea Minerals” or the “Company“), is pleased to announce that it has filed a listing application with the Nasdaq Capital Market (the “Nasdaq“) in connection with a planned uplisting of its common shares in the United States (“U.S.”). This strategic initiative is intended to support the Company’s long-term capital markets strategy by increasing its visibility with U.S. institutional and retail investors, broadening its potential shareholder base, and enhancing trading liquidity over time. The Company believes that a U.S. exchange listing, if completed, would complement...

VANCOUVER, British Columbia, May 29, 2026 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces it plans to pursue opportunities from the U.S. Department of War, following a recent Wall Street Journal article stating that the Trump administration is in discussions with U.S. drone companies and that it would begin considering new investments in U.S.-based drone manufacturers. As a leading emerging domestic drone manufacturer committed to a National Defense Authorization Act (NDAA)-compliant supply chain, the company believes its ZenaDrone subsidiary is well positioned to support the Defense Department. The Company intends...

CALGARY, Alberta, May 29, 2026 (GLOBE NEWSWIRE) — South Bow Corp. (TSX & NYSE: SOBO) (South Bow or the Company) announces the successful outcome of its open season, which closed on March 30, 2026, securing 20-year binding commitments for firm transportation service from Hardisty, Alta., to U.S. delivery points. South Bow will continue advancing its proposed Prairie Connector project toward a final investment decision (FID), targeted for mid-2027, while strictly adhering to the Company’s risk preferences and capital allocation priorities. Next steps include acquiring remaining permits and government assurances for permit durability, advancing execution plans, finalizing cost estimates, engaging with communities, landowners, Indigenous groups, and other stakeholders, and securing financing. The FID will be subject to the...